Meitheal Cetrorelix Acetate injection kit recalled for missing or duplicated needles
Meitheal Pharmaceuticals is recalling Cetrorelix Acetate 0.25 mg injection kits because some contain missing or duplicated needles in the delivery system. This affects lot Q4E0112A with an expiration date of April 30, 2027. The defect could prevent proper injection or cause unsafe handling.
From the FDA notice · Read the official notice ↗
What to do
- Check if you have lot Q4E0112A (expiration April 30, 2027)
- Stop using affected kits immediately
- Contact your pharmacy or healthcare provider for a replacement
- Do not attempt to use a kit with missing or extra needles
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 16,477 kits
- Illnesses reported
- None reported
- Manufactured in
- 8700 W Bryn Mawr Ave Ste 600s, N/A, Chicago, IL, United States
- Classification
- Class II
- Recall number
- D-0340-2026
In the FDA's words
- Description
- Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90. Defective Delivery System: Missing or duplicated needles within the injection kit Lot Q4E0112A, Exp.: 30 Apr 2027 Distribution: U.S. Nationwide Affected quantity: 16,477 kits
- Hazard
- Defective Delivery System: Missing or duplicated needles within the injection kit